Skip to main content
. 2011 Feb;9(1):69–78. doi: 10.1089/adt.2010.0309

Table 2.

Kinetic Parameters of the Selected Inhibitors

 
 
 
Inhibitor Concentrations, μM
ID NSC Kinetic Parameters 0 0.156 0.3125 0.625 1.25 2.5 5
1
NSC86314
VM, RFU/s
35.84 ± 0.26

34.65 ± 0.50
32.46 ± 0.59
28.77 ± 0.49
21.87 ± 0.70
13.10 ± 0.61
 
 
KM, μM
57.38 ± 1.02

51.79 ± 1.92
51.45 ± 2.40
46.38 ± 2.08
40.95 ± 3.59
25.02 ± 3.64
2
NSC716898
VM, RFU/s
34.24 ± 0.28

35.25 ± 0.24
35.94 ± 0.67
32.34 ± 0.26
27.27 ± 0.34
21.78 ± 0.66
 
 
KM, μM
48.84 ± 1.02

49.37 ± 0.86
54.75 ± 2.56
43.29 ± 0.92
36.83 ± 1.29
28.26 ± 2.60
3
NSC157058
VM, RFU/s
32.27 ± 0.59
32.87 ± 0.53
31.90 ± 0.50
30.18 ± 0.50
26.46 ± 0.68
24.08 ± 0.49

    KM, μM 44.17 ± 2.17 45.69 ± 1.97 45.93 ± 1.90 45.35 ± 2.01 40.87 ± 2.86 40.55 ± 2.26

The KM and Vmax values were determined using the purified WNV NS2B-NS2pro samples and the pyroglutamic acid-Arg-Thr-Lys-Arg-7-amino-4-methylcoumarin fluorescence-quenched peptide substrate in the presence of the indicated concentrations of the inhibitors.

RFU, relative fluorescence unit.